OSD contract manufacturing market valued at $54.7 billion by 2030
European Pharmaceutical Review
OCTOBER 7, 2022
A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Asia Pacific was the overall global market leader in 2021 and is expected to have the largest CAGR in the upcoming forecast period.
Let's personalize your content